5269 related articles for article (PubMed ID: 3375359)
1. Axillary lymphadenopathy: a complication of BCG immunotherapy for melanoma.
Briggs PC; Heckler FR
Plast Reconstr Surg; 1988 Jun; 81(6):952-3. PubMed ID: 3375359
[TBL] [Abstract][Full Text] [Related]
2. [Side effects of BCG immune therapy in 511 patients with malignant melanoma].
Schult C
Hautarzt; 1984 Feb; 35(2):78-83. PubMed ID: 6706581
[TBL] [Abstract][Full Text] [Related]
3. [Clinical administration of BCG-immunotherapy in malignant melanoma (author's transl)].
Wätzig V; Knopf B
Arch Geschwulstforsch; 1979; 49(2):140-5. PubMed ID: 475550
[TBL] [Abstract][Full Text] [Related]
4. Cromolyn prevents bronchospastic attacks caused by Bacillus Calmette Geurin immunotherapy for malignant melanoma patient.
Wishnitzer R; Eliraz A; Fink A
Ann Allergy; 1985 Aug; 55(2):167-9. PubMed ID: 3927789
[TBL] [Abstract][Full Text] [Related]
5. Distant cutaneous granulomas after bacille Calmette-Guérin immunotherapy for malignant melanoma: case for direct infection.
Moff SL; Corey GR; Gottfredsson M
Clin Infect Dis; 1999 Dec; 29(6):1569-70. PubMed ID: 10585816
[No Abstract] [Full Text] [Related]
6. Erythema multiforme as a complication of BCG scarification technique.
Tschen EH; Jessen RT; Robertson G; Becker LE
Arch Dermatol; 1979 May; 115(5):614-5. PubMed ID: 443840
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma.
Eilber FR; Morton DL; Holmes EC; Sparks FC; Ramming KP
N Engl J Med; 1976 Jan; 294(5):237-40. PubMed ID: 1244548
[TBL] [Abstract][Full Text] [Related]
8. [Use of immunotherapy in the treatment of malignant melanoma of the skin].
Kristensen E
Ugeskr Laeger; 1976 Feb; 138(8):468-73. PubMed ID: 1258215
[No Abstract] [Full Text] [Related]
9. A clinical trial of BCG immunotherapy as an adjunct to surgery in the treatment of primary malignant melanoma.
O'Connor TP; Labandter HP; Hiles RW; Bodenham DC
Br J Plast Surg; 1978 Oct; 31(4):317-22. PubMed ID: 361132
[TBL] [Abstract][Full Text] [Related]
10. Results of adjuvant BCG immunotherapy in malignant melanoma.
Wätzig V; Knopf B
Arch Geschwulstforsch; 1981; 51(6):493-6. PubMed ID: 7332442
[TBL] [Abstract][Full Text] [Related]
11. Epilesional scarification. Preliminary report of a new approach to local immunotherapy with BCG.
Richman SP; Mavligit GM; Wolk R; Gutterman JU; Hersh EM
JAMA; 1975 Dec; 234(12):1233-5. PubMed ID: 1242748
[TBL] [Abstract][Full Text] [Related]
12. Complete remission of metastatic malignant melanoma following immunotherapy with Bacillus Calmette-Guerin (BCG): report of a case.
Coates AS; Peters M
Aust N Z J Surg; 1977 Jun; 47(3):362-5. PubMed ID: 269705
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of melanoma with BCG: two fatalities following intralesional injection.
McKhann CF; Hendrickson CG; Spitler LE; Gunnarsson A; Banerjee D; Nelson WR
Cancer; 1975 Feb; 35(2):514-20. PubMed ID: 234291
[TBL] [Abstract][Full Text] [Related]
14. Experience with BCG adjuvant immunotherapy in stage II malignant melanoma.
Peter HH; Deutschmann EM; Schultheis W; Deicher H
Dev Biol Stand; 1977 Apr 13-15; 38():537-40. PubMed ID: 344106
[TBL] [Abstract][Full Text] [Related]
15. BCG immunotherapy in patients with malignant melanoma.
Karakousis CP; Douglass HO; Yeracaris PM; Holyoke ED
Arch Surg; 1976 Jun; 111(6):716-8. PubMed ID: 776125
[TBL] [Abstract][Full Text] [Related]
16. Granulomas in melanoma patients treated with BCG immunotherapy.
Hatzitheofilou C; Obenchain DF; Porter DD; Morton DL
Cancer; 1982 Jan; 49(1):55-60. PubMed ID: 7053820
[TBL] [Abstract][Full Text] [Related]
17. [Immunotherapy with BCG as coadjuvant in the management of malignant melanomas].
Céspedes de Gómez MM; Aguilar Velázquez G; Valles de Cortés Y
Alergia; 1980 Apr; 27(2):69-86. PubMed ID: 7416444
[No Abstract] [Full Text] [Related]
18. Primary inoculation tuberculosis after immunotherapy for malignant melanoma with BCG vaccine.
Caplan SE; Kauffman CL
J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):783-5. PubMed ID: 8912582
[No Abstract] [Full Text] [Related]
19. Pott's disease following BCG therapy of melanoma.
Strausser JL; Quindlen EA
Cancer; 1981 Sep; 48(5):1154-6. PubMed ID: 7272949
[TBL] [Abstract][Full Text] [Related]
20. [Cancer immunotherapy in dermatological view (author's transl)].
Lübbe D; Gstöttner R
Arch Geschwulstforsch; 1980; 50(2):182-5. PubMed ID: 7436703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
